Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Advances in Antiviral Drug Design
Advances in Antiviral Drug Design is not currently indexed in Scopus. Published by Elsevier Ltd.
Checked against the index lists dated .
ISSN 1075-8593Verify ISSN ↗
Publisher: Elsevier Ltd
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Advances in Antiviral Drug Design indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2007 (also 2003, 1999, 1996)).
What is the impact factor of Advances in Antiviral Drug Design?
Advances in Antiviral Drug Design has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Advances in Antiviral Drug Design and what is its ISSN?
Advances in Antiviral Drug Design is published by Elsevier Ltd. Its ISSN is 1075-8593.
Is Advances in Antiviral Drug Design in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Advances in Antiviral Drug Design open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Advances in Antiviral Drug Design for 4 years, between 1996 and 2007, with 8 years in that span missing. Coverage ended in 2007, 19 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 38 works and 362 citations for the title. Its most recent paper is from 2007, in line with the end of Scopus coverage in 2007, which suggests the journal stopped publishing around then.
How well cited is Advances in Antiviral Drug Design? — open metrics via OpenAlex
Advances in Antiviral Drug Design has an h-index of 11 and a 2-year mean of 0 citations per paper (OpenAlex).
Advances in Antiviral Drug Design published 11 papers in 2007. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Advances in Antiviral Drug Design? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2007. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2007
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Elsevier Ltd
Elsevier Ltd has 598 other titles in our data; 507 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.